 | Up a level |
Barco, Stefano; Virdone, Saverio; Götschi, Andrea; Ageno, Walter; Arcelus, Juan I; Bingisser, Roland; Colucci, Giuseppe; Cools, Frank; Duerschmied, Daniel; Gibbs, Harry; Fumagalli, Riccardo M; Gerber, Bernhard; Haas, Sylvia; Himmelreich, Jelle C L; Hobbs, Richard; Hobohm, Lukas; Jacobson, Barry; Kayani, Gloria; Lopes, Renato D; MacCallum, Peter; ... (2023). Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials. Thrombosis research, 230, pp. 27-32. Elsevier 10.1016/j.thromres.2023.08.009
Kotsia, Anna; Brilakis, Emmanouil S; Held, Claes; Cannon, Christopher; Steg, Gabriel P; Meier, Bernhard; Cools, Frank; Claeys, Marc J; Cornel, Jan H; Aylward, Philip; Lewis, Basil S; Weaver, Douglas; Brandrup-Wognsen, Gunnar; Stevens, Susanna R; Himmelmann, Anders; Wallentin, Lars; James, Stefan K (2014). Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. American Heart Journal, 168(1), 68-75.e2. Elsevier 10.1016/j.ahj.2014.04.001
Brilakis, Emmanouil S.; Held, Claes; Meier, Bernhard; Cools, Frank; Claeys, Marc J.; Cornel, Jan H.; Aylward, Philip; Lewis, Basil S.; Weaver, Douglas; Brandrup-Wognsen, Gunnar; Stevens, Susanna R.; Himmelmann, Anders; Wallentin, Lars; James, Stefan K. (2013). Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. American Heart Journal, 166(3), pp. 474-480. Elsevier 10.1016/j.ahj.2013.06.019
